Search

Objectives: To study the relationship between the ablation range and applied energy of laser ablation (LA) and microwave ablation (MWA) in papillary thyroid microcarcinoma (PTMC). Methods: A total of 201 PTMC patients were treated with LA (n = 102) or MWA (n = 99) with single-applicator fixed ablation. The ablation range was determined by contrast-enhanced ultrasound. The ratios of ablation volume, longitudinal diameter, and orthogonal diameter to ablation energy (RAV/E, RAL/E, RAO/E) were analyzed and compared between MWA and LA. The effects of PTMC characteristics and Hashimoto's thyroiditis (HT) on ablation efficiency were evaluated by linear regression. Results: The RAV/E was 0.72 (0.65–0.84) mm3/J for MWA and 0.48 (0.39–0.54) mm3/J for LA. HT was significantly correlated with RAV/E of LA (coefficient = − 0.367, p < 0.0001). RAL/E did not differ significantly between MWA and LA (MWA 0.026 mm/J, LA 0.025 mm/J; p = 0.957). However, MWA had a greater RAO/E than LA (MWA 0.014 mm/J, LA 0.012 mm/J; p < 0.0001). The plateau values of MWA and LA on the ablation orthogonal diameter were 10.7 mm and 8.69 mm, respectively. Conclusions: MWA showed a higher RAV/E than LA. More intuitively, MWA had a better ablation performance than LA on the orthogonal axis rather than the longitudinal axis. Theoretically, MWA and LA could achieve complete ablation of ≤ 6.70 mm and ≤ 4.69 mm PTMC separately by single-applicator fixed ablation considering a unilateral 2-mm safe margin. HT had a negative effect on LA but not on MWA. Clinical relevance statement: This study establishes strong connections between ablation energy and ablation range in papillary thyroid microcarcinoma (PTMC) in vivo, possibly contributing to the supplementation of the PTMC Ablation Consensus or Guidelines and providing a scientific basis for choosing clinical ablation parameters in PTMC. Key Points: • Both microwave ablation (MWA) and laser ablation (LA) have excellent performance on the ablation longitudinal axis (easily exceeding 10 mm) for papillary thyroid microcarcinoma (PTMC). • MWA performed much better than LA on the ablation orthogonal axis. • MWA and LA are expected to achieve complete ablation of ≤ 6.70 mm and ≤ 4.69 mm PTMC separately by single-applicator fixed ablation considering a unilateral 2-mm safe margin. [ABSTRACT FROM AUTHOR]

As an acute respiratory disease, scarlet fever has great harm to public health. Some evidence indicates that the time distribution pattern of heavy PM2.5 pollution occurrence may have an impact on health risks. This study aims to reveal the relation between scaling features in high-concentrations PM2.5 (HC-PM2.5) evolution and scarlet fever incidence (SFI). Based on the data of Hong Kong from 2012 to 2019, fractal box-counting dimension (D) is introduced to capture the scaling features of HC-PM2.5. It has been found that index D can quantify the time distribution of HC-PM2.5, and lower D values indicate more cluster distribution of HC-PM2.5. Moreover, scale-invariance in HC-PM2.5 at different time scales has been discovered, which indicates that HC-PM2.5 occurrence is not random but follows a typical power-law distribution. Next, the exposure–response relationship between SFI and scale-invariance in HC-PM2.5 is explored by Distributed lag non-linear model, in conjunction with meteorological factors. It has been discovered that scale-invariance in HC-PM2.5 has a nonlinear effect on SFI. Low and moderate D values of HC-PM2.5 are identified as risk factors for SFI at small time-scale. Moreover, relative risk shows a decreasing trend with the increase of exposure time. These results suggest that exposure to short-term clustered HC-PM2.5 makes individual more prone to SFI than exposure to long-term uniform HC-PM2.5. This means that individuals in slightly-polluted regions may face a greater risk of SFI, once the PM2.5 concentration keeps rising. In the future, it is expected that the relative risk of scarlet fever for a specific region can be estimated based on the quantitative analysis of scaling features in high-concentrations PM2.5 evolution. [ABSTRACT FROM AUTHOR]

In recent years, there has been a growing interest in the study of RNA modifications, with some researchers focusing specifically on the connection between these modifications and viruses, as well as the impact they have on viral mRNA and its functionality. The most common type of RNA chemical modification is m6A, which involves the addition of a methyl group covalently to the N6 position of adenosine. It is a widely observed and evolutionarily conserved RNA modification. The regulation of m6A modification primarily involves methyltransferases (writers) and demethylases (erasers) and is mediated by m6A-binding proteins (readers). In HIV-1, m6A sites are predominantly located in the 5′ untranslated region (5′UTR) and 3′ untranslated region (3′UTR). Additionally, m6A modifications are also present in the RRE RNA of HIV-1. This review provides a detailed account of the effects of these m6A modifications on HIV-1 functionality. [ABSTRACT FROM AUTHOR]

The "Shock and Kill" method is being considered as a potential treatment for eradicating HIV-1 and achieving a functional cure for acquired immunodeficiency syndrome (AIDS). This approach involves using latency-reversing agents (LRAs) to activate human immunodeficiency virus (HIV-1) transcription in latent cells, followed by treatment with antiviral drugs to kill these cells. Although LRAs have shown promise in HIV-1 patient research, their widespread clinical use is hindered by side effects and limitations. In this review, we categorize and explain the mechanisms of these agonists in activating HIV-1 in vivo and discuss their advantages and disadvantages. In the future, combining different HIV-1 LRAs may overcome their respective shortcomings and facilitate a functional cure for HIV-1. [ABSTRACT FROM AUTHOR]

Understanding the dynamic structural and chemical evolutions at the catalyst–electrolyte interfaces is crucial for the development of active and stable electrocatalysts. In this work, β-Li2IrO3 is employed as a model catalyst for the oxygen evolution reaction (OER). Its elastic three-dimensional Ir-O framework enables us to investigate the Li+ cation dissolution-induced structure evolutions and the formation mechanism of amorphous IrOx species. Electrochemical measurements by rotating ring disk electrode (RRDE) reveal that up to 60% of the measured OER current can be ascribed to catalyst degradation. A series of in-situ X-ray diffraction spectroscopy (XRD), X-ray absorption spectroscopy (XAS), and Raman spectroscopy are conducted. Structure vibration is observed with oxidation states of Ir being reduced abnormally during OER at high potentials. It's hypothesized that the reversible proton intercalations are responsible for the Ir turn-over mechanism. Results of this work demonstrate a stable and elastic iridate structure and reveal the initial catalyst degradation behaviors during OER in acid media. [ABSTRACT FROM AUTHOR]

Zirconia toughened alumina (ZTA) ceramics are commonly used in various industries. Adding suitable additives is an effective way to improve the performance of ZTA ceramics. However, the common reinforcement in ZTA, chromia (Cr2O3), tends to volatilize at high temperature in the presence of oxygen, limiting ceramic densification. Consequently, additional amounts of Cr2O3 are typically limited to below 1 wt%. In this study, spark plasma sintering was utilized to inhibit the volatilization of Cr2O3. Dense ZTA ceramics with high Cr2O3 content (from 1 to 10 wt%) were prepared at 1350 °C. The impact of the solid solution on the structure and properties of the ceramics was investigated. The findings demonstrate that the high Cr2O3 solution can regulate the grain size in the matrix, leading to an enhancement in both hardness and fracture toughness. The optimum performance of the sample was obtained with a 5 wt% dosage of Cr2O3, where the maximum values of Vickers hardness and fracture toughness were 20.66 GPa and 6.37 MPa m1/2, respectively. [ABSTRACT FROM AUTHOR]

In this paper, without converting the second-order inertial neural networks (INNs) into a first-order differential system by introducing variable substitution, the problem of passivity-based bipartite synchronization in a signed network composed by an array of coupled INNs with time-varying delay is investigated via quantized pinning control. By choosing an appropriate Lyapunov–Krasovskii functional (LKF), applying Jensen inequality and reciprocally convex inequality to estimate the derivative of the LKF, several sufficient conditions, which guarantee the bipartite leader-following synchronization for the coupled INNs with time-varying delay, are newly obtained in terms of linear matrix inequalities (LMIs). When the quantization is not considered in the pinning controller, the criterion of bipartite leader-following synchronization in terms of low-dimensional LMIs is established by using the properties of M-matrices. And the criterion of bipartite leaderless synchronization in terms of low-dimensional LMIs is also proposed by a matrix U. A numerical example is provided to demonstrate the effectiveness of the derived theoretical results. [ABSTRACT FROM AUTHOR]

Cerebrovascular disease is the leading cause of disability and death, and ischemic stroke accounts for most stroke cases. However, few effective drugs are available for the treatment of ischemic stroke; thus, there is an urgent need to develop effective drugs to treat ischemic stroke. DL-3-n-butylphthalide (NBP) is clinically approved as an anti-ischemic drug in China, but its potential hepatotoxicity limits its use. G-3702 (a structural analogue of NBP) is synthesized with the boron hydroxyl group replacing carbonyl group. G-3702 significantly enhanced the survival of middle cerebral artery occlusion (MCAO) rats, decreased neurobehavioral deficit scores and cerebral infarct volume, comparable with NBP, which was also supported by tissue damage assessment, immunohistochemistry staining, biochemical parameters and ELISA assay. G-3702 showed better anti-stroke activity than NBP according to 1H NMR spectroscopy-based metabolomics analysis, demonstrating the feasibility of metabolomics approach to assess drug efficacy. G-3702 markedly ameliorated energy metabolism, attenuated oxidative and inflammatory stress during ischemia/reperfusion (I/R). G-3702 exhibited good neuroprotective effects against I/R induced injury and favorable little possibility of hepatotoxicity, which made it a promising anti-stroke drug and better NBP alternative. [ABSTRACT FROM AUTHOR]